In-vivo buccal delivery of fluorescein isothiocyanate-dextran 4400 with glycodeoxycholate as an absorption enhancer in pigs

Journal of Pharmaceutical Sciences

Volumn 85, Issue 5, 1996, Pages 457-460

  Hoogstraate, A J ^a   Verhoef, J C ^a   Tuk, B ^a   Pijpers, A ^b   Van Leengoed, L A M G ^b   Verheijden, J H M ^b   Junginger, H E ^a   Bodde H E ^a,c  

^a LEIDEN UNIVERSITY   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c LEIDEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORESCEIN ISOTHIOCYANATE DEXTRAN; GLYCODEOXYCHOLIC ACID; PROPOFOL;

ABSORPTION; ANIMAL EXPERIMENT; ARTICLE; BUCCAL DRUG ADMINISTRATION; CHEEK MUCOSA; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG HALF LIFE; FEMALE; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; SWINE; WATER TRANSPORT;

EID: 0029914560     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1021/js950129k     Document Type: Article

References (27)

1. Lee, V. H. L. Enzymatic barriers to peptide and protein absorption. Crit. Rev. Ther. Drug Carrier Syst. 1988, 5, 69-97.
2. Squier, C. A.; Nanny, D. Measurements of blood flow in the oral mucosa and skin of the rhesus monkey using radiolabelled microspheres. Arch. Oral Biol. 1985, 30, 313-318.
3. De Vries, M. E.; Boddé, H. E.; Verhoef, J. C.; Junginger, H. E. Developments in buccal drug delivery. Crit. Rev. Ther. Drug Carrier Syst. 1991, 8, 271-303.
4. Nagai, T. Adhesive topical drug delivery systems. J. Controlled Release 1985, 2, 121-134.
5. Rathbone, J.; Hadgraft, J. Absorption of drugs from the human oral cavity. Int. J. Pharm. 1991, 74, 9-24.
6. Merkle, H. P.; Wolany, G. Buccal delivery for peptide drugs. J. Controlled Release 1992, 21, 155-164.
7. Ishida, M.; Machida, Y.; Nambu, N.; Nagai, T. New mucosal dosage form of insulin. Chem. Pharm. Bull. 1981, 28, 810-816.
8. Aungst, B. J.; Rogers, N. J. Comparison of the effects of various transmucosal absorption promoters on buccal insulin delivery. Int. J. Pharm. 1989, 53, 227-235.
9. Nakada, Y.; Awata, N.; Nakachima, C.; Sugimoto, I. The effects of additives on the oral mucosal absorption of human calcitonin in rats. J. Pharmacobio-Dyn. 1989, 12, 736-743.
10. Zhang, J.; Niu, S.; Ebert, C.; Stanley, T. H. An in-vivo dog model for studying recovering kinetics of the buccal mucosa permeation barrier after exposure to permeation enhancers: apparent evidence of effective enhancement without tissue damage. Int. J. Pharm. 1994, 101, 15-22.
11. Steward, A.; Bayley, D. L.; Howes, C. The effect of enhancers on the buccal absorption of hybrid (BDBB) α-interferon. Int. J. Pharm. 1994, 104, 145-149.
12. Lee, Y.; Chien, Y. W. Oral mucosal delivery of LHRH: (II) Enhancement of permeation by bile salts and evaluation of mechanism. Pharm. Res. 1994, 11, S300.
13. Ebert, C. D.; Heiber, S. J.; Dave, S. C. C.; Kim, S. W.; Mix, D. Mucosal delivery of macromolecules. J. Controlled Release 1994, 28, 37-44.
14. Gordon, G. S.; Moses, A. C.; Silver, R. D.; Flier, J. S.; Carey, M. C. Nasal absorption of insulin: Enhancement by hydrophobic bile salts. Proc. Natl. Acad. Sci. U.S.A. 1985, 82, 7419-7423.
15. 2]kyotorphin. Pharm. Res. 1990, 7, 127-133.
16. Shao, Z.; Mitra, A. K. Nasal membrane and intracellular protein and enzyme release by bile salts and bile salt-fatty acids mixed micelles. Correlation with facilitated drug transport. Pharm. Res. 1992, 9, 1184-1189.
17. Hoogstraate, A. J.; Senel, S.; Cullander, C.; Verhoef, J.; Junginger, H. E.; Boddé, H. E. Effects of bile salts on transport rates and routes of FITC-labelled compounds across porcine buccal epithelium in-vitro. J. Controlled Release accepted.
18. Lesch, C. A.; Squier, C. A.; Cruchley, A.; Williams, D. M.; Speight, P. The permeability of human oral mucosa and skin to water. J. Dent. Res. 1989, 68, 1345-1349.
19. Pijpers, A.; Noordhuizen-Stassen, E. N.; Goedegebuure, S. A.; van Dobbenburgh, O. A.; Roosendaal, M.; Cornelissen, A. H. M.; Verheijden, J. H. M. Intravenous catheterisation of conventional pigs without application of antimicrobial agents. Vet. Q. 1989, 11, 216-221.
20. Senel, S.; Hoogstraate, A. J.; Spies, F.; Verhoef, J. C.; Bos-van Geest, A.; Junginger, H. E.; Boddé, H. E. Enhancement of in-vitro permeability of porcine buccal mucosa by bile salts: kinetic and histological studies. J. Controlled Release 1994, 32, 45-56.
21. Hoogstraate, A. J.; Cullander, C.; Nagelkerke, F.; Senel, S.; Verhoef, J. C.; Junginger, H. E.; Boddé, H. E. Diffusion rates and transport pathways of FITC-labelled model compounds through buccal epithelium. Pharm. Res. 1994, 11, 83-89.
22. Gibaldi, M.; Perrier, D. Pharmacokinetics. In Drugs and the pharmaceutical sciences, 2nd ed.; Swarbrick, J., Ed.; Marcel Dekker: New York, 1975; Vol. 1, pp 409-424.
23. Mehvar, R.; Shepard, T. L. Molecular-weight-dependent pharmacokinetics of fluorescein-labelled dextrans in rats. J. Pharm. Sci. 1992, 81, 908-912.
24. Arturson, G.; Granath, K.; Thoren, L.; Wallenius, G. The renal excretion of low molecular weight dextran. Acta Chir. Scand. 1964, 127, 543-551.
25. Dubick, M. A.; Summary, J. J.; Ryan, B. A.; Wade, C. E. Dextran concentrations in plasma and urine following administration of 6% dextran-70/7.5% NaCl to haemorrhaged and euvolemic conscious swine. Circ. Shock 1989, 29, 301-310.
26. Oh, C. K.; Ritschel, W. A. Absorption characteristics of insulin through the buccal mucosa. Methods Find. Exp. Clin. Pharmacol. 1990, 12, 275-279.
27. Cassidy, J. P.; Landzert, N. M.; Quadros, E. Controlled buccal delivery of buprenorphine. J. Controled Release 1993, 25, 21-29.